Predictive factors of axillary pathological complete response in HER2-positive breast cancer patients treated with neoadjuvant chemotherapy - Poll - MDSpire

Predictive factors of axillary pathological complete response in HER2-positive breast cancer patients treated with neoadjuvant chemotherapy

  • By

  • Marta Rodríguez de Trujillo Campo-Cossío

  • Sara Romero-Martín

  • Beatriz Rodríguez-Alonso

  • Pilar Font-Ugalde

  • José Luis Raya-Povedano

  • Marina Álvarez-Benito

  • December 24, 2025

  • 0 min

Share

Original Source(s)

Predictive factors of axillary pathological complete response in HER2-positive breast cancer patients treated with neoadjuvant chemotherapy

  • by Marta Rodríguez de Trujillo Campo-Cossío, Sara Romero-Martín, Beatriz Rodríguez-Alonso, Pilar Font-Ugalde, José Luis Raya-Povedano, Marina Álvarez-Benito

  • December 24, 2025

Related Content

Efficacy Assessment of Radiotherapy Alone Versus Combined Surgery and Radiotherapy for Ipsilateral Supraclavicular Lymph Node Metastasis in Breast Cancer: A Retrospective Study with Eight-Year Follow-Up Utilizing Propensity Score Matching

A comparison of tumour characteristics of screen-detected and interval cancers and their relationship with breast density and AJCC prognostic stage in a UK screening cohort

Case Study: FAPI PET/CT Identifies Hidden Contralateral DCIS and Supraclavicular Metastasis, Informing Neoadjuvant Treatment in Synchronous Bilateral Breast Cancer